Hong Kong Consumer Finance Stock News

CiDi (SEHK:3881) has reported its FY 2025 figures, with first half revenue of ¥408.0 million and a basic EPS loss of ¥2.79. Trailing 12 month figures show revenue of ¥884.8 million and a basic EPS loss of ¥5.91, keeping profitability firmly in the red. The company’s revenue has moved from ¥132.6 million in 2H 2023 to ¥410.0 million in 2H 2024 and then to ¥408.0 million in 1H 2025. However, net income has remained negative across these periods, indicating that margins are still under clear...

United Energy Group (SEHK:467) has reported FY 2025 first half revenue of HK$8.1b and basic EPS of HK$0.0288, alongside net income of HK$740.1m, putting fresh numbers behind the recent shift in profitability and margins. The company has seen total revenue move from HK$8.4b in the first half of FY 2024 to HK$8.1b in the latest half, while basic EPS moved from HK$0.0390 to HK$0.0288 over the same periods. This gives you a clear view of how the top line and per share earnings are tracking into...

China Communications Services (SEHK:552) has put fresh numbers on the table for FY 2025, with first half revenue of C¥76.9b and basic EPS of C¥0.31 setting the tone against a trailing 12 month revenue base of about C¥150.1b and EPS of roughly C¥0.52. The company has seen revenue move from C¥74.4b in the first half of 2024 to C¥76.9b in the first half of 2025, while basic EPS has stayed close to the C¥0.31 mark over that period. This gives a clearer view of both business scale and per share...

CMBC Capital Holdings (SEHK:1141) has just posted its FY 2025 numbers, reporting first half revenue of HK$228.2 million and net income of HK$117.9 million. This translates into basic EPS of HK$0.107 per share. The company’s revenue moved from HK$190.6 million and EPS of HK$0.071 in the first half of FY 2024 to HK$228.2 million and HK$0.107 in the latest half. The trailing twelve month EPS is HK$0.138 on revenue of HK$370.4 million and net income of HK$151.2 million, which brings attention to...

China Renaissance Holdings (SEHK:1911) has reported FY 2025 first half revenue of C¥509 million and basic EPS of C¥0.13, with investors focused on how this compares with the recent trailing 12 month EPS of C¥0.19. The company has seen revenue move from C¥351.8 million and C¥471.7 million in the first and second halves of 2024 to the current C¥509 million, while EPS has shifted from losses of C¥0.15 and C¥0.20 per share in those periods to a positive C¥0.13. This sets the stage for a closer...

China Glass Holdings (SEHK:3300) has reported FY 2025 first half revenue of C¥2,153.5 million with a basic EPS loss of C¥0.15, while trailing twelve month figures show revenue of C¥5,207.6 million and basic EPS of C¥0.06. Over recent half year periods, the company has seen revenue move from C¥2,683.5 million in 1H FY 2024 to C¥3,054.1 million in 2H FY 2024 and then to C¥2,153.5 million in 1H FY 2025. Over the same intervals, EPS shifted from a loss of C¥0.07 to a loss of C¥0.45 and then to a...

China Ruyi Holdings (SEHK:136) has put up a clean headline for FY 2025, with first half revenue of C¥2.2b and basic EPS of C¥0.08, after reporting losses in both halves of FY 2024. The company has seen total revenue edge from about C¥1.8b in each half of FY 2024 to C¥2.2b in the first half of FY 2025, while net income has moved from losses of C¥115m and C¥76m in FY 2024 to a profit of C¥1.2b, pointing to a sharp reset in margins that puts profitability back at the center of the story. See our...

Hangzhou Jiuyuan Genetic Biopharmaceutical (SEHK:2566) has put fresh FY 2025 numbers on the table, with first half revenue of C¥638.8 million and basic EPS of C¥0.37 setting the tone for how the year is shaping up. Over recent halves the company has seen revenue move from C¥702.4 million and EPS of C¥0.53 in 1H 2024 to C¥666.8 million and EPS of C¥0.16 in 2H 2024, giving investors a clear view of how the current run rate compares with recent history. With trailing 12 month net profit margins...

Greentown China Holdings (SEHK:3900) has just reported FY 2025 results with first half revenue of C¥53.4b and basic EPS of C¥0.08, setting a restrained tone after a mixed prior year. Over the past three reported half year periods, revenue moved from C¥69.6b in 1H 2024 to C¥88.0b in 2H 2024 and now C¥53.4b in 1H 2025, while basic EPS shifted from C¥0.81 to a loss of C¥0.18 and then to C¥0.08. This has left investors focused squarely on how thin margins and volatile earnings shape the...

Jiangsu Guofu Hydrogen Energy Equipment (SEHK:2582) opened FY 2025 with first half revenue of C¥108.9 million and a basic EPS loss of C¥0.85, while net income excluding extra items was a loss of C¥89.2 million, setting a cautious tone around profitability. Over the prior first half periods, the company reported revenue of C¥64.3 million in 2024 H1 and C¥134.9 million in 2024 H2, alongside basic EPS losses of C¥0.98 and C¥1.14 respectively, which indicates a business still working through a...

Capital Finance Holdings (SEHK:8239) has posted its FY 2025 first half results with revenue of HK$14.5 million and a basic EPS loss of HK$0.086838, while the business remains loss making on a trailing 12 month basis. Over recent periods, revenue has moved from HK$5.97 million in 1H FY 2024 to HK$12.90 million in 2H FY 2024 and HK$14.49 million in 1H FY 2025, with EPS losses of HK$0.295337, HK$0.034645 and HK$0.086838 respectively as the company works through persistent negative net income...

Edianyun (SEHK:2416) has posted its FY 2025 results with second half revenue of C¥800.5 million and basic EPS of C¥0.16, set against a trailing twelve month revenue base of C¥1.5 billion and EPS of C¥0.25 that reflects reported earnings growth of 101% year over year. Over the last few reporting periods, the company has seen revenue move from C¥710.0 million in 2H 2024 to C¥699.6 million in 1H 2025 and C¥800.5 million in 2H 2025. Basic EPS shifted from C¥0.08 in 2H 2024 to C¥0.09 in 1H 2025...

China Gas Industry Investment Holdings (SEHK:1940) opened FY 2025 with first half revenue of C¥701.9 million and basic EPS of C¥0.062, setting a clear marker against last year’s second half revenue of C¥672.9 million and EPS of C¥0.065. The company has seen revenue move from C¥640.8 million in 1H 2024 to C¥701.9 million in 1H 2025, while EPS shifted from C¥0.043 to C¥0.062 over the same period, giving a clear view of how the top line and per share earnings have tracked across recent halves...

Metallurgical Corporation of China (SEHK:1618) closed FY 2025 with fourth quarter revenue of C¥120.3b and a net loss, excluding extra items, of C¥2.6b, setting a cautious tone for the latest set of numbers. Over recent quarters, the company has seen revenue move from C¥113.8b in Q3 2024 to C¥97.6b in Q3 2025, with EPS fluctuating between a loss of C¥0.09 in Q4 2024 and a positive C¥0.04 in Q3 2025. Meanwhile, trailing twelve month net margin has remained at a slim 0.3% compared to 0.9% in the...

Dalipal Holdings (SEHK:1921) has just reported its FY 2025 results with second half revenue of C¥1,768.9 million and basic EPS of C¥0.019, set against a first half where revenue was C¥1,693.6 million and EPS showed a loss of C¥0.010. Over the past year, revenue has moved between C¥1,752.8 million in the second half of FY 2024 and C¥1,768.9 million in the latest half. Over the same period, trailing twelve month basic EPS shifted from a loss of C¥0.053 to a profit of C¥0.009, giving investors a...

Beijing Geekplus Technology (SEHK:2590) has posted its FY 2025 numbers with first half revenue of C¥1.0b and a basic EPS loss of C¥0.04, while trailing twelve month revenue sits at about C¥3.2b against a net income loss of C¥10.4m. Over the past reported periods, the company has seen revenue move from C¥782.5m in the first half of 2024 to C¥1.0b in the first half of 2025 and trailing twelve month revenue track from C¥1.5b in 2022 to C¥3.2b in 2025, although EPS has stayed in loss making...

Sihuan Pharmaceutical Holdings Group (SEHK:460) has drawn investor attention after reporting full year 2025 earnings, showing CNY 2,618.01 million in sales and CNY 179.7 million in net income, alongside positive final Phase 3 data for Bireociclib. See our latest analysis for Sihuan Pharmaceutical Holdings Group. The earnings turnaround and Bireociclib news sit alongside a 17.9% 90 day share price return and a 121.2% 1 year total shareholder return. However, the 5 year total shareholder return...

China Lesso Group Holdings (SEHK:2128) has wrapped up FY 2025 with second half revenue of C¥11.8b and basic EPS of C¥0.07, set against trailing twelve month revenue of C¥24.3b and EPS of C¥0.41 that frame the broader earnings picture. The company has seen revenue shift from C¥13.5b and EPS of C¥0.21 in the second half of FY 2024 to C¥12.5b and EPS of C¥0.34 in the first half of FY 2025, before landing at these latest figures. This puts the focus squarely on how consistently profits are being...

HBM Holdings (SEHK:2142) just posted its FY 2025 first half scorecard, reporting revenue of US$101.3 million and basic EPS of US$0.09, with management highlighting very large year over year earnings growth over the last 12 months. The company has seen revenue move from US$23.7 million and US$14.4 million in the first and second halves of FY 2024 to US$101.3 million in the first half of FY 2025, while basic EPS shifted from roughly US$0.002 in each FY 2024 half to just over US$0.09, setting up...

Ubtech Robotics (SEHK:9880) has reported its FY 2025 results with second half revenue of C¥1.38b and a basic EPS loss of C¥0.61, framing a year where the business is still investing heavily in growth rather than delivering profits. The company has seen revenue move from C¥818.13m in the second half of 2024 to C¥621.46m in the first half of 2025 and then C¥1.38b in the second half of 2025. Over the same periods, basic EPS losses have shifted from C¥1.43 to C¥0.94 and then C¥0.61. For...

Beijing Saimo Technology (SEHK:2571) has reported FY 2025 first half revenue of C¥90.959 million and basic EPS of C¥0.010201, setting a cautious tone after a period where trailing 12 month EPS reached C¥0.43 on revenue of C¥262.447 million and year over year earnings growth was 4.8%. The company has seen revenue move from C¥221.883 million in the 2024 second half to C¥257.282 million on a trailing 12 month basis in the 2025 first half, with EPS shifting from C¥0.545109 to C¥0.525156 over the...

HealthyWay (SEHK:2587) has reported FY 2025 first half revenue of C¥517.9 million with basic EPS of C¥0.008, setting a cleaner earnings picture after a series of losses in FY 2024. Over recent periods the company has seen revenue move from C¥611.5 million in the first half of 2024 to C¥589.3 million in the second half of 2024 and then to C¥517.9 million in the first half of 2025. Net income shifted from a loss of C¥55.8 million and then C¥212.6 million in the 2024 halves to a profit of C¥7.1...

AEON Credit Service (Asia) (SEHK:900) has wrapped up FY 2026 with fourth quarter revenue of HK$756.0 million, Basic EPS of HK$0.28, and net income of HK$115.5 million. Trailing twelve month figures show revenue of HK$1.7 billion, EPS of HK$1.12, and net income of HK$468.2 million. Over recent quarters the company has seen quarterly revenue range from HK$317.1 million to HK$756.0 million and EPS move between HK$0.26 and HK$0.30. This sets up a picture where higher trailing revenue is paired...

Ever Sunshine Services Group (SEHK:1995) has posted FY 2025 first half revenue of C¥3.5b and basic EPS of C¥0.12, setting the tone for investors weighing the latest set of numbers. Over the last three reported halves, revenue has moved from C¥3.4b in 1H 2024 to C¥3.5b in 2H 2024 and C¥3.5b in 1H 2025, while basic EPS has ranged from C¥0.15 in 1H 2024 to roughly C¥0.12 in both 2H 2024 and 1H 2025, giving a steady, if unspectacular, picture of earnings power. With a trailing twelve month net...